Shopping Cart
- Remove All
Your shopping cart is currently empty
Tallimustine (FCE 24517), a distamycin-A derivative, is an anticancer agent.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,120 | 1-2 weeks | |
| 50 mg | $2,780 | 1-2 weeks | |
| 100 mg | $3,700 | 1-2 weeks |
| Description | Tallimustine (FCE 24517), a distamycin-A derivative, is an anticancer agent. |
| In vitro | SR31527 (50 µ M ; 24h) induced the formation of multiple Spindle apparatus in MDA-MB-231, BT549 and MDA-MB-435s cells.[1] SR31527 (0-100 µ M ; 96 hours, 10-12 days) reduces the cell viability and colony formation of breast cancer cells, and is less cytotoxic to LL47 cells.[1] |
| Synonyms | FCE 24517 |
| Molecular Weight | 697.61 |
| Formula | C32H38Cl2N10O4 |
| Cas No. | 115308-98-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.